129 related articles for article (PubMed ID: 35004530)
1. Case Report: Infusion-Related Reactions to Intravenous Infliximab and Subcutaneous Ustekinumab in Pediatric Crohn's Disease.
Kakiuchi T; Kimura S; Esaki M; Matsuo M
Front Pediatr; 2021; 9():670703. PubMed ID: 35004530
[No Abstract] [Full Text] [Related]
2. Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn's Disease Initiating Biologics With 3 Years of Follow-Up.
Zhao R; Ding Z; Gupta P; Gozalo L; Bruette R; Johnson VM; Maughn K; Liu Y; Kachroo S
J Health Econ Outcomes Res; 2023; 10(2):111-120. PubMed ID: 38025989
[No Abstract] [Full Text] [Related]
3. Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature.
Cortes X; Borrás-Blasco J; Antequera B; Fernandez-Martinez S; Casterá E; Martin S; Molés JR
J Clin Pharm Ther; 2017 Apr; 42(2):234-236. PubMed ID: 28004853
[TBL] [Abstract][Full Text] [Related]
4. Pustular Rash in Crohn's Patient on Ustekinumab Raises Concern for Drug-Induced Paradoxical Psoriasis.
Barahimi M; Lee S; Clark-Snustad K
Case Rep Gastroenterol; 2021; 15(2):662-666. PubMed ID: 34720824
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity Reaction to Ustekinumab in Pediatric and Young Adult Inflammatory Bowel Disease Patients: A Case Series.
Sunny J; Fonseca AG; Crim AM; Goyal A; Felipez LM
JPGN Rep; 2022 May; 3(2):e205. PubMed ID: 37168900
[TBL] [Abstract][Full Text] [Related]
6. Persistence, Dosing, and Other Treatment Patterns Among Crohn's Disease Patients Initiating Biologics in United States.
Teeple A; Sah J; Mallampati R; Adams C; Waters D; Muser E
Crohns Colitis 360; 2021 Oct; 3(4):otab076. PubMed ID: 36777272
[TBL] [Abstract][Full Text] [Related]
7. Crescentic IgA nephropathy after administration of human monoclonal interleukin-12/23p40 antibody in a patient with Crohn's disease: a case report.
Kanazawa N; Wada Y; Akiyama M; Shikida Y; Sugiyama M; Abe M; Iyoda M; Honda K; Shibata T
CEN Case Rep; 2020 Aug; 9(3):204-209. PubMed ID: 32100251
[TBL] [Abstract][Full Text] [Related]
8. Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing.
Argüelles-Arias F; Valdés Delgado T; Maldonado Pérez B; González Antuña J; Castro Laria L
Therap Adv Gastroenterol; 2023; 16():17562848231191670. PubMed ID: 37655058
[TBL] [Abstract][Full Text] [Related]
9. Safety Prediction of Infants Born to Mothers with Crohn's Disease Treated with Biological Agents in the Late Gestation Period.
Sako M; Yoshimura N; Sonoda A; Okano S; Ueda M; Tezuka M; Mine M; Yamanishi S; Hashimoto K; Kobayashi K; Takazoe M; Fukata M
J Anus Rectum Colon; 2021; 5(4):426-432. PubMed ID: 34746508
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Ustekinumab Versus Adalimumab in Induction of Clinical Response and Remission in Crohn's Disease: Experience of a Real-World Cohort at a Tertiary Care Inflammatory Bowel Disease Referral Center.
Ahmed Z; Venkata K; Zhang N; Malik TA
Gastroenterology Res; 2019 Oct; 12(5):245-251. PubMed ID: 31636774
[TBL] [Abstract][Full Text] [Related]
11. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
Davies SC; Nguyen TM; Parker CE; MacDonald JK; Jairath V; Khanna R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012804. PubMed ID: 31828765
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of Response.
Heron V; Li Fraine S; Panaccione N; Restellini S; Germain P; Candido K; Bernstein CN; Bessissow T; Bitton A; Chauhan UK; Lakatos PL; Marshall JK; Michetti P; Seow CH; Rosenfeld G; Panaccione R; Afif W
J Can Assoc Gastroenterol; 2022 Oct; 5(5):208-213. PubMed ID: 36196277
[TBL] [Abstract][Full Text] [Related]
13. Intensification with Intravenous Ustekinumab in Refractory Crohn's Disease.
Suárez Ferrer C; Arroyo Argüelles J; Rueda García JL; García Ramírez L; Martin Arranz E; Sánchez Azofra M; Poza Cordón J; Noci Belda J; Martin-Arranz MD
J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337361
[TBL] [Abstract][Full Text] [Related]
14. Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.
Painchart C; Brabant S; Duveau N; Nachury M; Desreumaux P; Branche J; Gérard R; Prevost CLD; Wils P; Lambin T; Boualit M; Labalette M; Pariente B
Dig Dis Sci; 2020 May; 65(5):1445-1452. PubMed ID: 31599389
[TBL] [Abstract][Full Text] [Related]
15. Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry.
Rahman P; Arendse R; Khraishi M; Sholter D; Sheriff M; Rampakakis E; Lehman AJ; Nantel F
BMJ Open; 2020 Aug; 10(8):e036245. PubMed ID: 32792436
[TBL] [Abstract][Full Text] [Related]
16. Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn's Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States.
Obando C; Ding Z; Muser E; Vaidya N; Qiang W; Sun X; Wang H; Mallampati R; Xie L
Adv Ther; 2020 May; 37(5):2127-2143. PubMed ID: 32193810
[TBL] [Abstract][Full Text] [Related]
17. Elective switching from infliximab to adalimumab in stable Crohn's disease.
Hoentjen F; Haarhuis BJ; Drenth JP; de Jong DJ
Inflamm Bowel Dis; 2013; 19(4):761-6. PubMed ID: 23446337
[TBL] [Abstract][Full Text] [Related]
18. Safety of Hydrocortisone Premedication Discontinuation in Patients with Inflammatory Bowel Disease on Maintenance Therapy with Infliximab: a Prospective Clinical and Pharmacological Study.
Tran-Minh ML; Gornet JM; Maillet M; Houze P; Simon M; McLellan P; Hassid D; Vivier-Chicoteau J; Baudry C; Hammoudi N; Allez M
J Crohns Colitis; 2021 May; 15(5):742-748. PubMed ID: 33205193
[TBL] [Abstract][Full Text] [Related]
19. Successful Drug Desensitization to Ustekinumab in a Patient with Crohn's Disease.
Cohen B; Tomer G; Gavrilova T
Case Rep Gastroenterol; 2021; 15(2):657-661. PubMed ID: 34720823
[TBL] [Abstract][Full Text] [Related]
20. Management of Paediatric Patients With Medically Refractory Crohn's Disease Using Ustekinumab: A Multi-Centred Cohort Study.
Chavannes M; Martinez-Vinson C; Hart L; Kaniki N; Chao CY; Lawrence S; Jacobson K; Hugot JP; Viala J; Deslandres C; Jantchou P; Seidman EG
J Crohns Colitis; 2019 Apr; 13(5):578-584. PubMed ID: 30541021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
